Skip to main content
logo
Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0230
-0.0031 (-11.88%)
At close: Oct 30, 2026

Adaptimmune Therapeutics Revenue

In the year 2025, Adaptimmune Therapeutics had annual revenue of $5.92M. Adaptimmune Therapeutics had revenue of $13.68M in the quarter ending June 30, 2025, a decrease of -89.33%. That makes Adaptimmune Therapeutics the 39,404th largest company in the world by revenue and 5,214th in the United States.

Revenue
5.92M
Revenue Growth
-96.62%
P/S Ratio
1.17
Revenue / Employee
21.78K
Employees
272
Market Cap
6.10M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.92M--
Dec 31, 2024---
Dec 31, 202360.28M33.13M122.05%
Dec 31, 202227.15M21.00M341.50%
Dec 31, 20216.15M2.19M55.36%
Dec 31, 20203.96M2.84M252.76%
Dec 31, 20191.12M-58.38M-98.11%
Dec 31, 201859.51M21.67M57.28%
Dec 31, 201737.83M23.64M166.47%
Dec 31, 201614.20M5.22M58.12%
Dec 31, 20158.98M-892.00K-9.04%
Jun 30, 20159.87M9.05M1,096.48%
Jun 30, 2014825.00K--
Jun 30, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Zeo ScientifiX8.80M
OSR Health1.81M
TRON Group1.01M
Oncotelic Therapeutics250.00K
Eastgate Biotech137.64K
VitaSpring Biomedical-1.49M
Revenue Rankings

Adaptimmune Therapeutics News

More News